Report Detail
Global Acute Lung Injury Market Insights, Forecast to 2025
- RnM3522862 |
- 14 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Other
Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema.
This kind of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.
Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness.
The global Acute Lung Injury market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acute Lung Injury market based on company, product type, end user and key regions.
This report studies the global market size of Acute Lung Injury in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acute Lung Injury in these regions.
This research report categorizes the global Acute Lung Injury market by top players/brands, region, type and end user. This report also studies the global Acute Lung Injury market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Altor BioScience
FirstString Research
GlaxoSmithKline
Forschung und Entwicklung
Commence Bio
CompleGen
Histocell S.L.
Stemedica Cell Technologies
Windtree Therapeutics
S-Evans Biosciences
Market size by Product
Pharmacotherapy
Mechanical Ventilation
Adjunctive Procedures
Fluid Management
Others
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Acute Lung Injury market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Acute Lung Injury market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Acute Lung Injury companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Acute Lung Injury submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Acute Lung Injury are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acute Lung Injury market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Acute Lung Injury Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Acute Lung Injury Market Size Growth Rate by Product
- 1.4.2 Pharmacotherapy
- 1.4.3 Mechanical Ventilation
- 1.4.4 Adjunctive Procedures
- 1.4.5 Fluid Management
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Acute Lung Injury Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Acute Lung Injury Market Size
- 2.1.1 Global Acute Lung Injury Revenue 2014-2025
- 2.1.2 Global Acute Lung Injury Sales 2014-2025
- 2.2 Acute Lung Injury Growth Rate by Regions
- 2.2.1 Global Acute Lung Injury Sales by Regions
- 2.2.2 Global Acute Lung Injury Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Acute Lung Injury Sales by Manufacturers
- 3.1.1 Acute Lung Injury Sales by Manufacturers
- 3.1.2 Acute Lung Injury Sales Market Share by Manufacturers
- 3.1.3 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
- 3.2 Acute Lung Injury Revenue by Manufacturers
- 3.2.1 Acute Lung Injury Revenue by Manufacturers (2014-2019)
- 3.2.2 Acute Lung Injury Revenue Share by Manufacturers (2014-2019)
- 3.3 Acute Lung Injury Price by Manufacturers
- 3.4 Acute Lung Injury Manufacturing Base Distribution, Product Types
- 3.4.1 Acute Lung Injury Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Acute Lung Injury Product Type
- 3.4.3 Date of International Manufacturers Enter into Acute Lung Injury Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Acute Lung Injury Sales by Product
- 4.2 Global Acute Lung Injury Revenue by Product
- 4.3 Acute Lung Injury Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Acute Lung Injury Breakdown Data by End User
6 North America
- 6.1 North America Acute Lung Injury by Countries
- 6.1.1 North America Acute Lung Injury Sales by Countries
- 6.1.2 North America Acute Lung Injury Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Acute Lung Injury by Product
- 6.3 North America Acute Lung Injury by End User
7 Europe
- 7.1 Europe Acute Lung Injury by Countries
- 7.1.1 Europe Acute Lung Injury Sales by Countries
- 7.1.2 Europe Acute Lung Injury Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Acute Lung Injury by Product
- 7.3 Europe Acute Lung Injury by End User
8 Asia Pacific
- 8.1 Asia Pacific Acute Lung Injury by Countries
- 8.1.1 Asia Pacific Acute Lung Injury Sales by Countries
- 8.1.2 Asia Pacific Acute Lung Injury Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Acute Lung Injury by Product
- 8.3 Asia Pacific Acute Lung Injury by End User
9 Central & South America
- 9.1 Central & South America Acute Lung Injury by Countries
- 9.1.1 Central & South America Acute Lung Injury Sales by Countries
- 9.1.2 Central & South America Acute Lung Injury Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Acute Lung Injury by Product
- 9.3 Central & South America Acute Lung Injury by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Acute Lung Injury by Countries
- 10.1.1 Middle East and Africa Acute Lung Injury Sales by Countries
- 10.1.2 Middle East and Africa Acute Lung Injury Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Acute Lung Injury by Product
- 10.3 Middle East and Africa Acute Lung Injury by End User
11 Company Profiles
- 11.1 Altor BioScience
- 11.1.1 Altor BioScience Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Altor BioScience Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Altor BioScience Acute Lung Injury Products Offered
- 11.1.5 Altor BioScience Recent Development
- 11.2 FirstString Research
- 11.2.1 FirstString Research Company Details
- 11.2.2 Company Business Overview
- 11.2.3 FirstString Research Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 FirstString Research Acute Lung Injury Products Offered
- 11.2.5 FirstString Research Recent Development
- 11.3 GlaxoSmithKline
- 11.3.1 GlaxoSmithKline Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline Acute Lung Injury Products Offered
- 11.3.5 GlaxoSmithKline Recent Development
- 11.4 Forschung und Entwicklung
- 11.4.1 Forschung und Entwicklung Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Forschung und Entwicklung Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Forschung und Entwicklung Acute Lung Injury Products Offered
- 11.4.5 Forschung und Entwicklung Recent Development
- 11.5 Commence Bio
- 11.5.1 Commence Bio Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Commence Bio Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Commence Bio Acute Lung Injury Products Offered
- 11.5.5 Commence Bio Recent Development
- 11.6 CompleGen
- 11.6.1 CompleGen Company Details
- 11.6.2 Company Business Overview
- 11.6.3 CompleGen Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 CompleGen Acute Lung Injury Products Offered
- 11.6.5 CompleGen Recent Development
- 11.7 Histocell S.L.
- 11.7.1 Histocell S.L. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Histocell S.L. Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Histocell S.L. Acute Lung Injury Products Offered
- 11.7.5 Histocell S.L. Recent Development
- 11.8 Stemedica Cell Technologies
- 11.8.1 Stemedica Cell Technologies Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Stemedica Cell Technologies Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Stemedica Cell Technologies Acute Lung Injury Products Offered
- 11.8.5 Stemedica Cell Technologies Recent Development
- 11.9 Windtree Therapeutics
- 11.9.1 Windtree Therapeutics Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Windtree Therapeutics Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Windtree Therapeutics Acute Lung Injury Products Offered
- 11.9.5 Windtree Therapeutics Recent Development
- 11.10 S-Evans Biosciences
- 11.10.1 S-Evans Biosciences Company Details
- 11.10.2 Company Business Overview
- 11.10.3 S-Evans Biosciences Acute Lung Injury Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 S-Evans Biosciences Acute Lung Injury Products Offered
- 11.10.5 S-Evans Biosciences Recent Development
12 Future Forecast
- 12.1 Acute Lung Injury Market Forecast by Regions
- 12.1.1 Global Acute Lung Injury Sales Forecast by Regions 2019-2025
- 12.1.2 Global Acute Lung Injury Revenue Forecast by Regions 2019-2025
- 12.2 Acute Lung Injury Market Forecast by Product
- 12.2.1 Global Acute Lung Injury Sales Forecast by Product 2019-2025
- 12.2.2 Global Acute Lung Injury Revenue Forecast by Product 2019-2025
- 12.3 Acute Lung Injury Market Forecast by End User
- 12.4 North America Acute Lung Injury Forecast
- 12.5 Europe Acute Lung Injury Forecast
- 12.6 Asia Pacific Acute Lung Injury Forecast
- 12.7 Central & South America Acute Lung Injury Forecast
- 12.8 Middle East and Africa Acute Lung Injury Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Acute Lung Injury Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Acute Lung Injury. Industry analysis & Market Report on Acute Lung Injury is a syndicated market report, published as Global Acute Lung Injury Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Acute Lung Injury market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
